BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8355460)

  • 1. Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients.
    Taylor JE; Belch JJ; McLaren M; Henderson IS; Stewart WK
    Kidney Int; 1993 Jul; 44(1):182-90. PubMed ID: 8355460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
    Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
    Borawski J; Pawlak K; Myśliwiec M
    Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor.
    Tobu M; Iqbal O; Fareed D; Chatha M; Hoppensteadt D; Bansal V; Fareed J
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):225-32. PubMed ID: 15247979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.
    Jaar B; Denis A; Viron B; Verdy E; Chamma F; Siohan P; Mignon F
    Am J Nephrol; 1997; 17(5):399-405. PubMed ID: 9382155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.
    Canaud B; Polito-Bouloux C; Garred LJ; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Am J Kidney Dis; 1990 Feb; 15(2):169-75. PubMed ID: 2301388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nifedipine on changes in fibrinogen and von Willebrand factor in haemodialysis patients treated with recombinant human erythropoietin.
    Taylor JE; Belch JJ; McLaren M; Stewart WK
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):100-4. PubMed ID: 7605873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients.
    De Marchi S; Cecchin E; Falleti E; Giacomello R; Stel G; Sepiacci G; Bortolotti N; Zanello F; Gonano F; Bartoli E
    J Am Soc Nephrol; 1997 Jul; 8(7):1147-56. PubMed ID: 9219165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
    Chen N; Qian JQ; Mei CL; Zhang AH; Xing CY; Wang L; Liu WH; Wang M; Chen JH; Liu BC; Hou FF; Chen XM; Zuo L; Shi W; Yu LB; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
    Kaizu K; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.
    Keven K; Kutlay S; Nergizoglu G; Ertürk S
    Am J Kidney Dis; 2003 Jun; 41(6):1233-9. PubMed ID: 12776276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
    Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
    Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.